ICD-10-CM Billable Code

M06.339

Rheumatoid nodule, unspecified wrist

Clinical Classification Guidelines

Medical Intelligence & Overview

Rheumatoid nodules are firm lumps that develop under the skin, most commonly near joints affected by rheumatoid arthritis. When these nodules occur specifically in the wrist, they can cause discomfort and may affect joint function. The medical code M06.339 refers to unspecified rheumatoid nodules located in the wrist, highlighting a condition associated with rheumatoid arthritis that requires medical monitoring and management.

Causes & Symptoms

Clinical Causes: Rheumatoid arthritis, an autoimmune disorder where the immune system mistakenly attacks the body's own tissues, primarily joints. Chronic inflammation of the joint tissues leading to the formation of granulomatous nodules. Genetic predisposition and environmental factors that can increase the risk of rheumatoid arthritis and nodules. Presence of circulating rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies contributing to the formation of nodules.

Key Symptoms: Firm, subcutaneous lumps typically located over the wrist or nearby areas. Nodules may be painless but can sometimes cause discomfort or tenderness. Swelling or inflammation in the wrist joint adjacent to the nodule. Limited range of motion or stiffness in the affected wrist, especially if the nodule interferes with joint movement. In some cases, skin over the nodule may become ulcerated or broken, leading to possible infection.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and imaging studies. Medical professionals typically perform a physical examination to identify the size, location, and characteristics of the nodules. Additional diagnostic tools may include: - Ultrasound imaging to assess the nodule's composition and relationship to surrounding tissues. - Magnetic Resonance Imaging (MRI) for detailed visualization of joint and soft tissue involvement. - Blood tests to detect rheumatoid factor (RF), anti-CCP antibodies, and markers of inflammation such as ESR and CRP. - Biopsy of the nodule may be performed when necessary to confirm the diagnosis and rule out other conditions. These assessments help distinguish rheumatoid nodules from other types of skin lumps or soft tissue tumors.

Treatment Protocols: Management of rheumatoid nodules often involves addressing the underlying rheumatoid arthritis. Treatment options may include: - Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate or sulfasalazine to control inflammation and slow nodule growth. - Biologic agents targeting specific components of the immune response, like anti-TNF medications. - Corticosteroids to reduce inflammation and nodule size, either systemically or locally if necessary. - Surgical removal of the nodule might be considered if it causes significant discomfort, interferes with joint function, or becomes ulcerated. - Regular monitoring and management of rheumatoid arthritis to prevent further nodule development and joint damage. It is essential to work with healthcare professionals specialized in rheumatology for an individualized treatment plan.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M06.339 a billable ICD-10 code?
Yes, M06.339 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M06.339?
Clinical documentation must specify the nature of Rheumatoid nodule, unspecified wrist and any associated comorbidities for accurate reporting.

Cite this Clinical Reference